Shah Nikita
Insider CIK 1738061 · AMRX SVP, Chief HR Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMRX Amneal Pharmaceuticals, In | S Sale | 2026-08-12 | 2026-08-13 | 146,403 | $17.51 | $2.56M | 253,390 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2026-08-12 | 2026-08-13 | 146,403 | $17.51 | $2.56M | 253,390 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-04 | 2026-03-05 | 35,880 | — | $0 | 71,760 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-04 | 2026-03-05 | 17,976 | $13.30 | $239.1K | 399,793 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-04 | 2026-03-05 | 35,880 | — | $0 | 417,769 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-03 | 2026-03-05 | 45,871 | — | $0 | 45,872 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-03 | 2026-03-05 | 36,232 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-03 | 2026-03-05 | 23,544 | — | $0 | 70,634 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-03 | 2026-03-05 | 366,972 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-03 | 2026-03-05 | 36,232 | — | $0 | 182,635 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-03 | 2026-03-05 | 18,502 | $13.31 | $246.3K | 164,133 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-03 | 2026-03-05 | 45,871 | — | $0 | 210,004 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-03 | 2026-03-05 | 22,982 | $13.31 | $305.9K | 187,022 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-03 | 2026-03-05 | 23,544 | — | $0 | 210,566 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-03 | 2026-03-05 | 11,796 | $13.31 | $157.0K | 198,770 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-03 | 2026-03-05 | 366,972 | — | $0 | 565,742 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-03 | 2026-03-05 | 183,853 | $13.31 | $2.45M | 381,889 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2026-03-02 | 2026-03-03 | 65,359 | — | $0 | 65,359 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2026-03-02 | 2026-03-03 | 65,359 | — | $0 | 65,359 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-11-12 | 2025-11-14 | 95,525 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-11-12 | 2025-11-14 | 36,331 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2025-11-12 | 2025-11-14 | 131,856 | $11.92 | $1.57M | 146,403 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-11-12 | 2025-11-14 | 36,331 | $2.75 | $99.9K | 182,734 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-11-12 | 2025-11-14 | 95,525 | $2.75 | $262.7K | 278,259 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2025-08-25 | 2025-08-25 | 6,340 | $9.50 | $60.2K | 146,403 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2025-08-22 | 2025-08-25 | 114,492 | $9.66 | $1.11M | 152,743 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2025-08-14 | 2025-08-15 | 71,694 | $9.29 | $666.0K | 267,235 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2025-08-12 | 2025-08-13 | 50,000 | $9.04 | $452.0K | 338,929 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2025-05-16 | 2025-05-19 | 49,140 | $7.58 | $372.5K | 388,929 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-04 | 2025-03-05 | 35,879 | — | $0 | 107,640 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-04 | 2025-03-05 | 35,879 | — | $0 | 456,422 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-04 | 2025-03-05 | 18,353 | $8.84 | $162.2K | 438,069 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2025-03-03 | 2025-03-05 | 94,178 | — | $0 | 94,178 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-03 | 2025-03-05 | 36,232 | — | $0 | 36,232 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-03 | 2025-03-05 | 144,928 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2025-03-03 | 2025-03-05 | 188,356 | — | $0 | 188,356 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-03 | 2025-03-05 | 45,872 | — | $0 | 91,743 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-03 | 2025-03-05 | 45,872 | — | $0 | 373,210 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-03 | 2025-03-05 | 23,464 | $8.76 | $205.5K | 349,746 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-03 | 2025-03-05 | 144,928 | — | $0 | 494,674 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-03 | 2025-03-05 | 74,131 | $8.76 | $649.4K | 420,543 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-03 | 2025-03-05 | 18,533 | $8.76 | $162.3K | 327,338 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-03 | 2025-03-05 | 36,232 | — | $0 | 345,871 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-01 | 2025-03-04 | 28,958 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-01 | 2025-03-04 | 28,958 | — | $0 | 320,624 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-01 | 2025-03-04 | 10,985 | $8.67 | $95.2K | 309,639 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2024-08-14 | 2024-08-16 | 100,000 | $7.75 | $775.0K | 291,666 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2024-03-04 | 2024-03-05 | 287,038 | — | $0 | 287,038 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2024-03-04 | 2024-03-05 | 143,519 | — | $0 | 143,519 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2024-03-03 | 2024-03-05 | 45,871 | — | $0 | 137,615 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2024-03-03 | 2024-03-05 | 36,232 | — | $0 | 72,464 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2024-03-03 | 2024-03-05 | 45,871 | — | $0 | 414,648 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2024-03-03 | 2024-03-05 | 36,232 | — | $0 | 386,930 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2024-03-03 | 2024-03-05 | 18,153 | $5.47 | $99.3K | 368,777 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2024-03-03 | 2024-03-05 | 22,982 | $5.47 | $125.7K | 391,666 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2024-03-01 | 2024-03-05 | 28,957 | — | $0 | 28,958 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2024-03-01 | 2024-03-05 | 15,181 | $5.47 | $83.0K | 350,698 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2024-03-01 | 2024-03-05 | 28,957 | — | $0 | 365,879 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2024-02-27 | 2024-02-29 | 35,620 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2024-02-27 | 2024-02-29 | 35,620 | — | $0 | 355,592 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2024-02-27 | 2024-02-29 | 18,670 | $5.71 | $106.6K | 336,922 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2023-03-03 | 2023-03-07 | 366,972 | — | $0 | 366,972 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2023-03-03 | 2023-03-07 | 183,486 | — | $0 | 183,486 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2023-03-03 | 2023-03-07 | 36,232 | — | $0 | 108,696 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2023-03-03 | 2023-03-07 | 18,064 | $1.92 | $34.7K | 319,972 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2023-03-03 | 2023-03-07 | 36,232 | — | $0 | 338,036 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2023-03-01 | 2023-03-03 | 28,958 | — | $0 | 57,915 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2023-03-01 | 2023-03-03 | 11,729 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2023-03-01 | 2023-03-03 | 28,958 | — | $0 | 317,359 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2023-03-01 | 2023-03-03 | 6,504 | $2.09 | $13.6K | 288,401 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2023-03-01 | 2023-03-03 | 15,555 | $2.09 | $32.5K | 301,804 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2023-03-01 | 2023-03-03 | 11,729 | — | $0 | 294,905 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2023-02-27 | 2023-03-01 | 35,620 | — | $0 | 35,620 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2023-02-27 | 2023-03-01 | 35,620 | — | $0 | 302,928 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2023-02-27 | 2023-03-01 | 19,752 | $2.16 | $42.7K | 283,176 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2022-05-07 | 2022-05-10 | 4,442 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2022-05-07 | 2022-05-10 | 4,442 | — | $0 | 269,536 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2022-05-07 | 2022-05-10 | 2,228 | $3.40 | $7.6K | 267,308 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2022-03-03 | 2022-03-03 | 289,856 | — | $0 | 289,856 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2022-03-03 | 2022-03-03 | 144,928 | — | $0 | 144,928 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2022-03-01 | 2022-03-03 | 28,957 | — | $0 | 86,873 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2022-03-01 | 2022-03-03 | 11,728 | — | $0 | 11,729 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2022-03-01 | 2022-03-03 | 8,905 | $4.45 | $39.6K | 265,094 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2022-03-01 | 2022-03-03 | 28,957 | — | $0 | 273,999 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2022-03-01 | 2022-03-03 | 3,607 | $4.45 | $16.1K | 245,042 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2022-03-01 | 2022-03-03 | 11,728 | — | $0 | 248,649 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2022-02-27 | 2022-03-01 | 35,620 | — | $0 | 71,240 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2022-02-27 | 2022-03-01 | 11,695 | $4.59 | $53.7K | 236,921 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2022-02-27 | 2022-03-01 | 35,620 | — | $0 | 248,616 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2021-12-15 | 2021-12-17 | 2,000 | $3.95 | $7.9K | 212,996 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2021-05-07 | 2021-05-11 | 4,441 | — | $0 | 4,442 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2021-05-07 | 2021-05-11 | 1,366 | $5.20 | $7.1K | 214,996 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2021-05-07 | 2021-05-11 | 4,441 | — | $0 | 216,362 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2021-03-15 | 2021-03-17 | 36,330 | — | $0 | 36,331 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2021-03-15 | 2021-03-17 | 36,330 | $2.75 | $99.9K | 248,251 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2021-03-15 | 2021-03-17 | 36,330 | $6.87 | $249.6K | 211,921 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2021-03-01 | 2021-03-02 | 11,729 | — | $0 | 23,457 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2021-03-01 | 2021-03-03 | 231,660 | — | $0 | 231,660 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2021-03-01 | 2021-03-03 | 115,830 | — | $0 | 115,830 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2021-03-01 | 2021-03-02 | 11,729 | — | $0 | 215,528 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2021-03-01 | 2021-03-02 | 3,607 | $5.18 | $18.7K | 211,921 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2021-02-27 | 2021-03-02 | 35,620 | — | $0 | 106,860 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2021-02-27 | 2021-03-02 | 35,620 | — | $0 | 215,347 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2021-02-27 | 2021-03-02 | 11,548 | $5.39 | $62.2K | 203,799 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2020-05-07 | 2020-05-08 | 4,442 | — | $0 | 8,883 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2020-05-07 | 2020-05-08 | 4,442 | — | $0 | 181,053 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2020-05-07 | 2020-05-08 | 1,326 | $3.55 | $4.7K | 179,727 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2020-03-01 | 2020-03-03 | 11,728 | — | $0 | 35,186 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2020-03-01 | 2020-03-03 | 4,228 | $3.85 | $16.3K | 176,611 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2020-03-01 | 2020-03-03 | 11,728 | — | $0 | 180,839 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2020-02-27 | 2020-03-02 | 284,960 | — | $0 | 284,960 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2020-02-27 | 2020-03-02 | 142,480 | — | $0 | 142,480 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | D To issuer deriv | 2019-11-13 | 2019-11-14 | 72,661 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | D To issuer deriv | 2019-11-13 | 2019-11-14 | 95,525 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-11-13 | 2019-11-14 | 72,661 | — | $0 | 72,661 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-11-13 | 2019-11-14 | 95,525 | — | $0 | 95,525 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2019-05-07 | 2019-05-09 | 4,441 | — | $0 | 13,325 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2019-05-07 | 2019-05-09 | 1,366 | $13.44 | $18.4K | 169,111 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2019-05-07 | 2019-05-09 | 4,441 | — | $0 | 170,477 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-03-01 | 2019-03-05 | 95,525 | — | $0 | 95,525 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-03-01 | 2019-03-05 | 46,914 | — | $0 | 46,914 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2018-08-21 | 2018-08-23 | 50,000 | $23.46 | $1.17M | 166,036 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | J Other | 2018-07-05 | 2018-07-09 | 216,036 | — | $0 | 216,036 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-07 | 2018-05-09 | 72,661 | — | $0 | 72,661 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-07 | 2018-05-09 | 17,766 | — | $0 | 17,766 | SEC↗ |